_id
6919e2083c536f8df2317f70
Ticker
0RA9.LSE
Name
Abivax S.A.
Exchange
LSE
Address
7-11 boulevard Haussmann, Paris, France, 75009
Country
UK
Sector
Industry
Currency
EUR
Website
https://www.abivax.com
Description
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Last Close
121
Volume
2445
Current Price
106.2
Change
-2.975206611570243
Last Updated
2025-12-29T14:46:13.237Z
Image
https://logo.clearbit.com/www.abivax.com
Ipo Date
-
Market Cap
1109011712
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
2017000
Cost Of Revenue
-
Gross Profit
2017000
Operating Expenses
95713000
Operating Income
-93696000
Interest Expense
3521000
Pretax Income
-100784000
Net Income
-100784000
Eps
-1.5894101229452509
Dividends Per Share
-
Shares Outstanding
9980780
Income Tax Expense
-
EBITDA
-93594000
Operating Margin
-4645.314823996034
Total Other Income Expense Net
-7088000
Cash
60946000
Short Term Investments
-
Receivables
14737000
Inventories
-
Total Current Assets
86102000
Property Plant Equipment
2159000
Total Assets
119641000
Payables
57497000
Short Term Debt
48844000
Long Term Debt
-
Total Liabilities
167921000
Equity
-48280000
Bs_currency_symbol
-
Depreciation
524000
Change In Working Capital
2287000
Cash From Operations
-66617999
Capital Expenditures
63000
Cash From Investing
1269000
Cash From Financing
-8767000
Net Change In Cash
-42630000
Cf_currency_symbol
EUR
PE
-
PB
-139.4802996188898
ROE
208.7489643744822
ROA
-84.23868071982012
FCF
-66680999
Fcf Percent
-33.059493802677245
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
1
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2017000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
2017000
Quarters > 0 > income Statement > operating Expenses
95713000
Quarters > 0 > income Statement > operating Income
-93696000
Quarters > 0 > income Statement > interest Expense
3521000
Quarters > 0 > income Statement > pretax Income
-100784000
Quarters > 0 > income Statement > net Income
-100784000
Quarters > 0 > income Statement > eps
-1.5894101229452509
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
63409688
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-93594000
Quarters > 0 > income Statement > operating Margin
-4645.314823996034
Quarters > 0 > income Statement > total Other Income Expense Net
-7088000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
60946000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
14737000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
86102000
Quarters > 0 > balance Sheet > property Plant Equipment
2159000
Quarters > 0 > balance Sheet > total Assets
119641000
Quarters > 0 > balance Sheet > payables
57497000
Quarters > 0 > balance Sheet > short Term Debt
48844000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
167921000
Quarters > 0 > balance Sheet > equity
-48280000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-100784000
Quarters > 0 > cash Flow > depreciation
524000
Quarters > 0 > cash Flow > change In Working Capital
2287000
Quarters > 0 > cash Flow > cash From Operations
-66617999
Quarters > 0 > cash Flow > capital Expenditures
63000
Quarters > 0 > cash Flow > cash From Investing
1269000
Quarters > 0 > cash Flow > cash From Financing
-8767000
Quarters > 0 > cash Flow > net Change In Cash
-42630000
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
-1.5894101229452509
Quarters > 0 > ratios > PB
-139.4802996188898
Quarters > 0 > ratios > ROE
208.7489643744822
Quarters > 0 > ratios > ROA
-84.23868071982012
Quarters > 0 > ratios > FCF
-66680999
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-33.059493802677245
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
4006000
Quarters > 1 > income Statement > cost Of Revenue
524000
Quarters > 1 > income Statement > gross Profit
4006000
Quarters > 1 > income Statement > operating Expenses
96993000
Quarters > 1 > income Statement > operating Income
-105435000
Quarters > 1 > income Statement > interest Expense
6220000
Quarters > 1 > income Statement > pretax Income
-98590000
Quarters > 1 > income Statement > net Income
-94604000
Quarters > 1 > income Statement > eps
-1.4979178871700682
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
63157000
Quarters > 1 > income Statement > income Tax Expense
-3986000
Quarters > 1 > income Statement > EBITDA
-91847000
Quarters > 1 > income Statement > operating Margin
-2631.9271093359957
Quarters > 1 > income Statement > total Other Income Expense Net
6845000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
144221000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
15663000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
170671000
Quarters > 1 > balance Sheet > property Plant Equipment
2666000
Quarters > 1 > balance Sheet > total Assets
205228000
Quarters > 1 > balance Sheet > payables
30748000
Quarters > 1 > balance Sheet > short Term Debt
43769000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
164644000
Quarters > 1 > balance Sheet > equity
40584000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-94604000
Quarters > 1 > cash Flow > depreciation
524000
Quarters > 1 > cash Flow > change In Working Capital
14468000
Quarters > 1 > cash Flow > cash From Operations
-70339000
Quarters > 1 > cash Flow > capital Expenditures
404000
Quarters > 1 > cash Flow > cash From Investing
-995000
Quarters > 1 > cash Flow > cash From Financing
-7374000
Quarters > 1 > cash Flow > net Change In Cash
-78096000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-1.4979178871700682
Quarters > 1 > ratios > PB
165.26890892962746
Quarters > 1 > ratios > ROE
-233.10664301202445
Quarters > 1 > ratios > ROA
-46.09702379792231
Quarters > 1 > ratios > FCF
-70743000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-17.659261108337493
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
6786000
Quarters > 2 > income Statement > cost Of Revenue
576000
Quarters > 2 > income Statement > gross Profit
6786000
Quarters > 2 > income Statement > operating Expenses
86783000
Quarters > 2 > income Statement > operating Income
-79997000
Quarters > 2 > income Statement > interest Expense
7891000
Quarters > 2 > income Statement > pretax Income
-84303000
Quarters > 2 > income Statement > net Income
-81638000
Quarters > 2 > income Statement > eps
-1.2975192093254437
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
62918529
Quarters > 2 > income Statement > income Tax Expense
-2665000
Quarters > 2 > income Statement > EBITDA
-79825000
Quarters > 2 > income Statement > operating Margin
-1178.8535219569703
Quarters > 2 > income Statement > total Other Income Expense Net
-4306000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
222317000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
16364000
Quarters > 2 > balance Sheet > inventories
2944000
Quarters > 2 > balance Sheet > total Current Assets
242985000
Quarters > 2 > balance Sheet > property Plant Equipment
2574000
Quarters > 2 > balance Sheet > total Assets
284492000
Quarters > 2 > balance Sheet > payables
17428000
Quarters > 2 > balance Sheet > short Term Debt
38106000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
158022000
Quarters > 2 > balance Sheet > equity
126470000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-81638000
Quarters > 2 > cash Flow > depreciation
576000
Quarters > 2 > cash Flow > change In Working Capital
4023000
Quarters > 2 > cash Flow > cash From Operations
-85175000
Quarters > 2 > cash Flow > capital Expenditures
236000
Quarters > 2 > cash Flow > cash From Investing
13458000
Quarters > 2 > cash Flow > cash From Financing
40322000
Quarters > 2 > cash Flow > net Change In Cash
-29625000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-1.2975192093254437
Quarters > 2 > ratios > PB
52.83425144144856
Quarters > 2 > ratios > ROE
-64.55127698268363
Quarters > 2 > ratios > ROA
-28.696061752175805
Quarters > 2 > ratios > FCF
-85411000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-12.586354258768052
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
2245000
Quarters > 3 > income Statement > cost Of Revenue
378000
Quarters > 3 > income Statement > gross Profit
1867000
Quarters > 3 > income Statement > operating Expenses
92422000
Quarters > 3 > income Statement > operating Income
-90177000
Quarters > 3 > income Statement > interest Expense
5700000
Quarters > 3 > income Statement > pretax Income
-95787000
Quarters > 3 > income Statement > net Income
-95787000
Quarters > 3 > income Statement > eps
-1.9070354511055558
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
50228222
Quarters > 3 > income Statement > income Tax Expense
-2258000
Quarters > 3 > income Statement > EBITDA
-90047000
Quarters > 3 > income Statement > operating Margin
-4016.7928730512253
Quarters > 3 > income Statement > total Other Income Expense Net
-5691000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
251942000
Quarters > 3 > balance Sheet > short Term Investments
9050000
Quarters > 3 > balance Sheet > receivables
19098000
Quarters > 3 > balance Sheet > inventories
1
Quarters > 3 > balance Sheet > total Current Assets
285972000
Quarters > 3 > balance Sheet > property Plant Equipment
878000
Quarters > 3 > balance Sheet > total Assets
327062000
Quarters > 3 > balance Sheet > payables
15880000
Quarters > 3 > balance Sheet > short Term Debt
10607000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
131052000
Quarters > 3 > balance Sheet > equity
196010000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-95787000
Quarters > 3 > cash Flow > depreciation
377000
Quarters > 3 > cash Flow > change In Working Capital
12046000
Quarters > 3 > cash Flow > cash From Operations
-69531000
Quarters > 3 > cash Flow > capital Expenditures
117000
Quarters > 3 > cash Flow > cash From Investing
-8783000
Quarters > 3 > cash Flow > cash From Financing
218548000
Quarters > 3 > cash Flow > net Change In Cash
137561000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-1.9070354511055558
Quarters > 3 > ratios > PB
27.21410732309576
Quarters > 3 > ratios > ROE
-48.86842508035304
Quarters > 3 > ratios > ROA
-29.28710764319915
Quarters > 3 > ratios > FCF
-69648000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-31.023608017817374
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
10792000
Annuals > 0 > income Statement > cost Of Revenue
1100000
Annuals > 0 > income Statement > gross Profit
10792000
Annuals > 0 > income Statement > operating Expenses
184332000
Annuals > 0 > income Statement > operating Income
-185432000
Annuals > 0 > income Statement > interest Expense
14111000
Annuals > 0 > income Statement > pretax Income
-182893000
Annuals > 0 > income Statement > net Income
-176242000
Annuals > 0 > income Statement > eps
-2.7954509405830663
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
63046000
Annuals > 0 > income Statement > income Tax Expense
-6651000
Annuals > 0 > income Statement > EBITDA
-167682000
Annuals > 0 > income Statement > operating Margin
-1718.235730170497
Annuals > 0 > income Statement > total Other Income Expense Net
2539000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
144221000
Annuals > 0 > balance Sheet > short Term Investments
136000
Annuals > 0 > balance Sheet > receivables
15663000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
170671000
Annuals > 0 > balance Sheet > property Plant Equipment
2665000
Annuals > 0 > balance Sheet > total Assets
205228000
Annuals > 0 > balance Sheet > payables
43824000
Annuals > 0 > balance Sheet > short Term Debt
43769000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
164644000
Annuals > 0 > balance Sheet > equity
40584000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-176242000
Annuals > 0 > cash Flow > depreciation
1100000
Annuals > 0 > cash Flow > change In Working Capital
1423000
Annuals > 0 > cash Flow > cash From Operations
-154072000
Annuals > 0 > cash Flow > capital Expenditures
643000
Annuals > 0 > cash Flow > cash From Investing
15762000
Annuals > 0 > cash Flow > cash From Financing
28207000
Annuals > 0 > cash Flow > net Change In Cash
-107721000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-2.7954509405830663
Annuals > 0 > ratios > PB
195.11575004928048
Annuals > 0 > ratios > ROE
-434.26473487088504
Annuals > 0 > ratios > ROA
-85.87619623053384
Annuals > 0 > ratios > FCF
-154715000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-14.33608228317272
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
4621000
Annuals > 1 > income Statement > cost Of Revenue
128000
Annuals > 1 > income Statement > gross Profit
4493000
Annuals > 1 > income Statement > operating Expenses
131950000
Annuals > 1 > income Statement > operating Income
-127376000
Annuals > 1 > income Statement > interest Expense
13826000
Annuals > 1 > income Statement > pretax Income
-152233000
Annuals > 1 > income Statement > net Income
-147740000
Annuals > 1 > income Statement > eps
-3.4305484605024845
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
43066000
Annuals > 1 > income Statement > income Tax Expense
-4493000
Annuals > 1 > income Statement > EBITDA
-133207000
Annuals > 1 > income Statement > operating Margin
-2756.4596407703957
Annuals > 1 > income Statement > total Other Income Expense Net
-24857000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
251942000
Annuals > 1 > balance Sheet > short Term Investments
9050000
Annuals > 1 > balance Sheet > receivables
19099000
Annuals > 1 > balance Sheet > inventories
-999
Annuals > 1 > balance Sheet > total Current Assets
285972000
Annuals > 1 > balance Sheet > property Plant Equipment
878000
Annuals > 1 > balance Sheet > total Assets
327062000
Annuals > 1 > balance Sheet > payables
21953000
Annuals > 1 > balance Sheet > short Term Debt
10607000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
131052000
Annuals > 1 > balance Sheet > equity
196010000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-147740000
Annuals > 1 > cash Flow > depreciation
707000
Annuals > 1 > cash Flow > change In Working Capital
21265000
Annuals > 1 > cash Flow > cash From Operations
-97130000
Annuals > 1 > cash Flow > capital Expenditures
265000
Annuals > 1 > cash Flow > cash From Investing
-8095000
Annuals > 1 > cash Flow > cash From Financing
335290000
Annuals > 1 > cash Flow > net Change In Cash
224992000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-3.4305484605024845
Annuals > 1 > ratios > PB
27.595987959797966
Annuals > 1 > ratios > ROE
-75.37370542319269
Annuals > 1 > ratios > ROA
-45.17186343873639
Annuals > 1 > ratios > FCF
-97395000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-21.076606795066002
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4583000
Annuals > 2 > income Statement > cost Of Revenue
71000
Annuals > 2 > income Statement > gross Profit
4512000
Annuals > 2 > income Statement > operating Expenses
56575000
Annuals > 2 > income Statement > operating Income
-64836000
Annuals > 2 > income Statement > interest Expense
7022000
Annuals > 2 > income Statement > pretax Income
-65215999
Annuals > 2 > income Statement > net Income
-60740000
Annuals > 2 > income Statement > eps
-3.1813635992713767
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19092442
Annuals > 2 > income Statement > income Tax Expense
-4476000
Annuals > 2 > income Statement > EBITDA
-53315000
Annuals > 2 > income Statement > operating Margin
-1414.7065241108444
Annuals > 2 > income Statement > total Other Income Expense Net
-380000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
26944000
Annuals > 2 > balance Sheet > short Term Investments
6000
Annuals > 2 > balance Sheet > receivables
8316000
Annuals > 2 > balance Sheet > inventories
12187000
Annuals > 2 > balance Sheet > total Current Assets
48191000
Annuals > 2 > balance Sheet > property Plant Equipment
322000
Annuals > 2 > balance Sheet > total Assets
73352000
Annuals > 2 > balance Sheet > payables
15475000
Annuals > 2 > balance Sheet > short Term Debt
30034000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
71470000
Annuals > 2 > balance Sheet > equity
7189000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-69846000
Annuals > 2 > cash Flow > depreciation
71000
Annuals > 2 > cash Flow > change In Working Capital
-10089000
Annuals > 2 > cash Flow > cash From Operations
-65579000
Annuals > 2 > cash Flow > capital Expenditures
3968000
Annuals > 2 > cash Flow > cash From Investing
-3727000
Annuals > 2 > cash Flow > cash From Financing
32211000
Annuals > 2 > cash Flow > net Change In Cash
-33751000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-3.1813635992713767
Annuals > 2 > ratios > PB
333.566659507581
Annuals > 2 > ratios > ROE
-844.9019335095285
Annuals > 2 > ratios > ROA
-82.80619478678155
Annuals > 2 > ratios > FCF
-69547000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-15.174994545057823
Annuals > 2 > health Score
9
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
37000
Annuals > 3 > income Statement > cost Of Revenue
156000
Annuals > 3 > income Statement > gross Profit
-119000
Annuals > 3 > income Statement > operating Expenses
52031000
Annuals > 3 > income Statement > operating Income
-52187000
Annuals > 3 > income Statement > interest Expense
3558000
Annuals > 3 > income Statement > pretax Income
-45561000
Annuals > 3 > income Statement > net Income
-42452000
Annuals > 3 > income Statement > eps
-2.746637210127775
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
15455991
Annuals > 3 > income Statement > income Tax Expense
-4204000
Annuals > 3 > income Statement > EBITDA
-42195000
Annuals > 3 > income Statement > operating Margin
-141045.94594594595
Annuals > 3 > income Statement > total Other Income Expense Net
6626000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
60695000
Annuals > 3 > balance Sheet > short Term Investments
6000
Annuals > 3 > balance Sheet > receivables
8339000
Annuals > 3 > balance Sheet > inventories
4000000
Annuals > 3 > balance Sheet > total Current Assets
74713000
Annuals > 3 > balance Sheet > property Plant Equipment
93000
Annuals > 3 > balance Sheet > total Assets
110365000
Annuals > 3 > balance Sheet > payables
18558000
Annuals > 3 > balance Sheet > short Term Debt
10232000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
81591000
Annuals > 3 > balance Sheet > equity
25933000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-41357000
Annuals > 3 > cash Flow > depreciation
156000
Annuals > 3 > cash Flow > change In Working Capital
-1414000
Annuals > 3 > cash Flow > cash From Operations
-45657000
Annuals > 3 > cash Flow > capital Expenditures
1642000
Annuals > 3 > cash Flow > cash From Investing
-1456000
Annuals > 3 > cash Flow > cash From Financing
82679000
Annuals > 3 > cash Flow > net Change In Cash
31399000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-2.746637210127775
Annuals > 3 > ratios > PB
74.85722706975668
Annuals > 3 > ratios > ROE
-163.69876219488683
Annuals > 3 > ratios > ROA
-38.46509310016762
Annuals > 3 > ratios > FCF
-47299000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1278.3513513513512
Annuals > 3 > health Score
9
Valuation > metrics > PE
-1.5894101229452509
Valuation > metrics > PB
-139.4802996188898
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
208.7489643744822
Profitability > metrics > ROA
-117.05186871385101
Profitability > metrics > Net Margin
-49.96727813584531
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-26.610621982391365
Risk > final Score
-76
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.8096782990568078
Liquidity > metrics > Quick Ratio
0.8096782990568078
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-62
Prev Risks > 1
-11
Prev Risks > 2
-15
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:58:43.104Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-09-30
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-2.1024
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-08
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.7631
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.8263
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Abivax S.A.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.1024
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.